Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EDGE

Edge Therapeutics (EDGE) Stock Price, News & Analysis

Edge Therapeutics logo

About Edge Therapeutics Stock (NASDAQ:EDGE)

Advanced Chart

Key Stats

Today's Range
$41.79
$41.79
50-Day Range
$0.50
$6.71
52-Week Range
$0.28
$17.38
Volume
158 shs
Average Volume
373,201 shs
Market Capitalization
$1.32 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EDGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Edge Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EDGE Stock News Headlines

Is This Stock the 'Next Nvidia'?
'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, and has now reached every AI company in America... including Nvidia, Microsoft, and Meta.tc pixel
See More Headlines

EDGE Stock Analysis - Frequently Asked Questions

Edge Therapeutics, Inc. (NASDAQ:EDGE) issued its quarterly earnings results on Thursday, November, 1st. The biotechnology company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.16.

Based on aggregate information from My MarketBeat watchlists, some other companies that Edge Therapeutics investors own include ContraFect (CFRX), McEwen (MUX), Arena Pharmaceuticals (ARNA), BioLineRx (BLRX), Bristol Myers Squibb (BMY), Cerecor (CERC) and CRISPR Therapeutics (CRSP).

Company Calendar

Last Earnings
11/01/2018
Today
8/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:EDGE
CIK
1472091
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$40.86 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-81.29%
Return on Assets
-56.92%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.59
Quick Ratio
5.59

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.95 per share
Price / Book
43.99

Miscellaneous

Outstanding Shares
31,510,000
Free Float
N/A
Market Cap
$1.32 billion
Optionable
Not Optionable
Beta
3.65
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:EDGE) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners